On May 28, 2015, the Federal Trade Commission (FTC) announced the settlement of its 2008 lawsuit against Cephalon, Inc. (now owned by Teva Pharmaceutical Industries, Ltd.), which alleged that Cephalon had made “reverse...more
6/2/2015
/ Abbreviated New Drug Application (ANDA) ,
Cephalon ,
Disgorgement ,
Federal Trade Commission (FTC) ,
FTC v Actavis ,
Generic Drugs ,
Hatch-Waxman ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Settlement ,
Teva Pharmaceuticals